NASDAQ (NASDAQ.NDX)

Close: 12 131.00 (+390.48), May 27, 2022
Negative

Automatic technical analysis. Medium term, May 27, 2022

NASDAQ is in a falling trend channel in the medium long term. This signals increasing pessimism among investors and indicates further decline for NASDAQ. The index has broken a resistance level in the short term and given a positive signal for the short-term trading range. There is no support in the price chart and further decline is indicated. In case of a positive reaction, the index has resistance at 12600 points. RSI diverges positively against the price, which indicates a possibility for a reaction up. The index is overall assessed as technically negative for the medium long term.

Recommendation one to six months: Negative (Score: -76)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.10%0.00+3.33%
5 days0.003.47%0.00+6.84%
22 days0.008.90%0.00-2.87%
66 days0.0015.16%0.00-6.95%

More analyses of NASDAQ

chart NASDAQ (NASDAQ) Candlesticks 22 Days
Candlesticks
chart NASDAQ (NASDAQ) Short term
Short term: Weak Positive
chart NASDAQ (NASDAQ) Medium term
Medium term: Negative
chart NASDAQ (NASDAQ) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+